Pages that link to "Q37004889"
Jump to navigation
Jump to search
The following pages link to Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects (Q37004889):
Displaying 50 items.
- Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release (Q24804783) (← links)
- Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs (Q26766294) (← links)
- Biomarkers in chronic obstructive pulmonary disease: confusing or useful? (Q27690280) (← links)
- Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence (Q33743024) (← links)
- Serine proteinase inhibitor therapy in alpha(1)-antitrypsin inhibitor deficiency and cystic fibrosis (Q33760369) (← links)
- Alpha-1-antitrypsin deficiency: what next? (Q33944534) (← links)
- The use of chromatography to manufacture purer and safer plasma products (Q34187883) (← links)
- Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy (Q34249676) (← links)
- A review of augmentation therapy for alpha-1 antitrypsin deficiency (Q34268108) (← links)
- α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy (Q34428735) (← links)
- Evaluation of "at risk" alpha 1-antitrypsin genotype SZ with synthetic oligonucleotide gene probes (Q34521234) (← links)
- Production of glycosylated physiologically "normal" human alpha 1-antitrypsin by mouse fibroblasts modified by insertion of a human alpha 1-antitrypsin cDNA using a retroviral vector (Q34597261) (← links)
- Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema (Q34980209) (← links)
- Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes (Q35063726) (← links)
- Adverse effects of neutrophils on the lung (Q35229751) (← links)
- Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis (Q35233352) (← links)
- Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep (Q35815514) (← links)
- Augmentation therapy for alpha(1)-antitrypsin deficiency (Q35859010) (← links)
- High-level production of biologically active human alpha 1-antitrypsin in Escherichia coli. (Q36252984) (← links)
- Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency (Q36284086) (← links)
- The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency. (Q36308010) (← links)
- Alpha-1-antitrypsin deficiency: current concepts (Q36846798) (← links)
- Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency (Q36968194) (← links)
- Multilineage transduction of resident lung cells in vivo by AAV2/8 for α1-antitrypsin gene therapy (Q37051733) (← links)
- Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase (Q37173117) (← links)
- Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency. (Q37303247) (← links)
- Alpha 1-antitrypsin deficiency: pathogenesis and treatment (Q37320922) (← links)
- Mechanism of alpha-1 antitrypsin endocytosis by lung endothelium (Q37326944) (← links)
- Targeted treatment in COPD: a multi-system approach for a multi-system disease (Q37340178) (← links)
- Understanding Lung Deposition of Alpha-1 Antitrypsin in Acute Experimental Mouse Lung Injury Model Using Fluorescence Microscopy (Q37516657) (← links)
- Alpha-1 antitrypsin (AAT) deficiency - what are the treatment options? (Q37614554) (← links)
- Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies (Q37774788) (← links)
- Emerging drugs for alpha-1-antitrypsin deficiency (Q37780552) (← links)
- Lung deposition of inhaled Alpha-1-proteinase inhibitor (Alpha1-PI) - problems and experience of Alpha1-PI inhalation therapy in patients with hereditary Alpha1-PI deficiency and cystic fibrosis (Q37819431) (← links)
- The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency (Q37894093) (← links)
- Molecular biology and respiratory disease. 7. The alpha 1 antitrypsin gene and chronic lung disease (Q38000235) (← links)
- Alpha-1 antitrypsin augmentation therapy (Q38092897) (← links)
- Alpha-1 antitrypsin deficiency: new developments in augmentation and other therapies (Q38114852) (← links)
- Current status of gene therapy for α-1 antitrypsin deficiency (Q38264336) (← links)
- Therapeutics: Gene Therapy for Alpha-1 Antitrypsin Deficiency (Q38650541) (← links)
- Therapeutic compositions and uses of alpha1-antitrypsin: a patent review (2012 - 2015). (Q38769762) (← links)
- Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease (Q38937862) (← links)
- alpha-1-Antitrypsin and the pathogenesis of emphysema (Q39593971) (← links)
- Neonatal hepatitis with obstructive jaundice in an SZ heterozygous alpha 1-antitrypsin-deficient boy and destructive lung disease in his SZ mother. A review of the literature (Q39812968) (← links)
- Alpha(1)-antitrypsin inhibits epithelial Na transport in vitro and in vivo (Q39897500) (← links)
- Measurement of soluble proteins in lung secretions (Q40176364) (← links)
- Analysis of Macrophage Differentiation and Function with Monoclonal Antibodies (Q40179696) (← links)
- Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2. (Q40503317) (← links)
- Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group (Q40774389) (← links)
- Chronic obstructive pulmonary disease: less common causes--an algorithm for the primary care physician (Q40795968) (← links)